Aravive Inc (ARAV) concluded trading on 01/11/24 at a closing price of $0.11, with 3.67 million shares of worth about $0.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.08% during that period and on Thursday the price saw a loss of about -0.09%. Currently the company’s common shares owned by public are about 59.84M shares, out of which, 45.11M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the ARAV stock and their offered price forecasts bring an average price target of $10.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $10.00 and could fall to a lowest price of $10.00. The stock’s current price level is 98.9% above of average price target set by the analysts, while a rise to estimated low would result in gain of 98.9% for the stock. However, touching the estimated high of $10.00 would mean a gain of 98.9% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
However, the stock later moved at a day high price of 0.1169, or with a loss of -0.09%. Stock saw a price change of -4.91% in past 5 days and over the past one month there was a price change of -9.58%. Year-to-date (YTD), ARAV shares are showing a performance of -7.68% which decreased to -93.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.11 but also hit the highest price of $2.46 during that period. The average intraday trading volume for Aravive Inc shares is 5.66 million. The stock is currently trading -8.82% below its 20-day simple moving average (SMA20), while that difference is down -13.63% for SMA50 and it goes to -85.75% lower than SMA200.
Aravive Inc (NASDAQ: ARAV) currently have 59.84M outstanding shares and institutions hold larger chunk of about 8.17% of that.
The stock has a current market capitalization of $8.40M and its 3Y-monthly beta is at 2.19. It has posted earnings per share of -$0.96 in the same period. It has Quick Ratio of 0.98 while making debt-to-equity ratio of 1.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARAV, volatility over the week remained 6.64% while standing at 7.32% over the month.
Analysts are in expectations that Aravive Inc (ARAV) stock would likely to be making an EPS of $Aravive, Inc. in the current quarter, while forecast for next quarter EPS is $0.11 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Accuray Incorporated which is $ARAX HLDGS CORP at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Russell 3000 Value in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 90.29% while it is estimated to increase by 56.23% in next year.
Analysts at 1 brokerage firms have issued recommendations for the Aravive Inc (ARAV)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.50. Out of those 1 Wall Street analysts, 0 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on April 17, 2023 offering a Buy rating for the stock and assigned a target price of $12 to it.
